Zhu H - Search Results

1

Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.

Weng Q, Zhang J, Cao J, Xia Q, Wang D, Hu Y, Sheng R, Wu H, Zhu D, Zhu H, He Q, Yang B. Weng Q, et al. Among authors: zhu d, zhu h. Invest New Drugs. 2011 Dec;29(6):1177-87. doi: 10.1007/s10637-010-9462-y. Epub 2010 Jun 5. Invest New Drugs. 2011. PMID: 20524035

2

ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells.

Cao J, Xu D, Wang D, Wu R, Zhang L, Zhu H, He Q, Yang B. Cao J, et al. Among authors: zhu h. Free Radic Biol Med. 2009 Sep 1;47(5):536-47. doi: 10.1016/j.freeradbiomed.2009.05.024. Epub 2009 May 28. Free Radic Biol Med. 2009. PMID: 19482076

3

XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro.

Wu R, Ding W, Liu T, Zhu H, Hu Y, Yang B, He Q. Wu R, et al. Among authors: zhu h. Cancer Lett. 2009 Nov 18;285(1):13-22. doi: 10.1016/j.canlet.2009.04.042. Epub 2009 Aug 3. Cancer Lett. 2009. PMID: 19647933

4

P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.

Zhang C, Zhu H, Yang X, Lou J, Zhu D, Lu W, He Q, Yang B. Zhang C, et al. Among authors: zhu d, zhu h. J Cancer Res Clin Oncol. 2010 Mar;136(3):437-45. doi: 10.1007/s00432-009-0674-5. Epub 2009 Sep 2. J Cancer Res Clin Oncol. 2010. PMID: 19727814

5

Antimetastatic activity of MONCPT in preclinical melanoma mice model.

Yang XC, Tu CX, Luo PH, Zhu H, Zhu DF, Wu HH, Zhou XL, Lu W, He QJ, Yang B. Yang XC, et al. Among authors: zhu df, zhu h. Invest New Drugs. 2010 Dec;28(6):800-11. doi: 10.1007/s10637-009-9323-8. Epub 2009 Sep 30. Invest New Drugs. 2010. PMID: 19789842

6

Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol.

Zhu H, Ding WJ, Wu R, Weng QJ, Lou JS, Jin RJ, Lu W, Yang B, He QJ. Zhu H, et al. Cancer Invest. 2010 Jan;28(1):23-32. doi: 10.3109/07357900903095664. Cancer Invest. 2010. PMID: 19916747

7

MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer.

Zhu Y, Jiang H, Zhang C, He QJ, Yang B, Li LJ, Zhu H. Zhu Y, et al. Among authors: zhu h. Pharmazie. 2009 Dec;64(12):823-8. Pharmazie. 2009. PMID: 20095141

8

Synergistic antitumor effect of TRAIL in combination with sunitinib in vitro and in vivo.

Ding W, Cai T, Zhu H, Wu R, Tu C, Yang L, Lu W, He Q, Yang B. Ding W, et al. Among authors: zhu h. Cancer Lett. 2010 Jul 28;293(2):158-66. doi: 10.1016/j.canlet.2010.01.005. Epub 2010 Feb 6. Cancer Lett. 2010. PMID: 20137855

9

Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cells.

Jing H, Zhou X, Dong X, Cao J, Zhu H, Lou J, Hu Y, He Q, Yang B. Jing H, et al. Among authors: zhu h. Cancer Lett. 2010 Aug 28;294(2):167-77. doi: 10.1016/j.canlet.2010.01.035. Epub 2010 Feb 18. Cancer Lett. 2010. PMID: 20167420

10

Novel combretastatin A-4 derivative XN0502 induces cell cycle arrest and apoptosis in A549 cells.

Zhu H, Zhang J, Xue N, Hu Y, Yang B, He Q. Zhu H, et al. Invest New Drugs. 2010 Aug;28(4):493-501. doi: 10.1007/s10637-010-9424-4. Epub 2010 Mar 30. Invest New Drugs. 2010. PMID: 20352291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,831 results

Search Page

Filters